Related Experiment Video

Updated: Dec 31, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

981

The many questions that surround multicentric and multifocal breast cancer

Seema A Khan

    The Breast Journal
    |June 23, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
    04:21

    Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

    Published on: January 26, 2024

    1.3K
    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    18.7K

    Related Experiment Videos

    Last Updated: Dec 31, 2025

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
    10:37

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

    Published on: August 22, 2025

    981
    Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
    04:21

    Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

    Published on: January 26, 2024

    1.3K
    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    18.7K

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    7.1K
    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    7.1K
    Cancer Stem Cells and Tumor Maintenance02:40

    Cancer Stem Cells and Tumor Maintenance

    5.8K
    Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
    Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
    5.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels.

    Cancer prevention research (Philadelphia, Pa.)·2026

    Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).

    Frontiers in immunology·2026

    Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer prevention.

    International journal of cancer·2025

    Medium-Chain Fatty Acid exposure in non-transformed mammary glands leads to pro-tumorigenic alterations associated with aging.

    bioRxiv : the preprint server for biology·2025

    USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I.

    The Journal of clinical investigation·2025

    Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical Trial.

    JAMA oncology·2025

    Study on the Pathway Mechanism of Social Support and Quality of Life Between Self-Disclosure and Stigma Among Breast Cancer Patients During Recovery.

    The breast journal·2026

    Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.

    The breast journal·2026

    An Algorithm for Salvage of Implant-Threatening Complications in Breast Reconstruction.

    The breast journal·2026

    Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.

    The breast journal·2026

    rs2357322 and rs17726078 Contribute to Breast Cancer Risk by Regulating DLX2 Expression.

    The breast journal·2026

    Implementation and Audit of Mainstream Genetic Testing Within a High-Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion.

    The breast journal·2026

    Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.

    Frontiers in immunology·2026

    Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.

    Frontiers in cell and developmental biology·2026

    RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.

    International journal of surgery (London, England)·2026

    CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

    Clinical and translational medicine·2026

    CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

    Asia-Pacific journal of clinical oncology·2026

    Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.

    Biogerontology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us